ArticleOncology letters2025
Adenoid cystic carcinoma of the breast with aggressive behavior: A case report and review of the literature.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Primary adenoid cystic carcinoma of the breast: a clinicopathological case series.Korean journal of clinical oncology · 2026Article
- Seven Shades of Triple Negativity: A Review Unveiling the Low-Grade Spectrum of Breast Cancer.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenoid cystic carcinoma (AdCC) of the breast is a subtype of triple-negative breast cancer characterized by a distinct indolent behavior, with extremely rare lymphatic involvement and a late onset of distant metastasis occurring several years post-diagnosis. Due to its favorable prognosis, therapeutic guidelines include surgical resection with adjuvant radiotherapy, with no significant benefit of chemotherapy. The present study discusses the case of a 77-year-old female patient who presented with a right-sided breast mass. Biopsy confirmed a grade 2 AdCC transitioning to a higher grade in some areas. The patient underwent a wide local excision and adjuvant radiotherapy was planned; however, during a simulation computed tomography scan performed 6 weeks after surgery, a complex mass at the ipsilateral axillary tail was detected and proved to be disease recurrence on biopsy. Restaging imaging studies showed metastatic involvement of the regional lymph nodes, lungs, liver, bones and brain. The patient received three cycles of palliative chemotherapy, but then clinically deteriorated and passed away 7 months after the initial diagnosis. Notably, the relatively large tumor size (6.4 cm) and the presence of high-grade morphology may have contributed to the poor outcome of the patient. In addition, the current case is one of the unique reported instances in the literature where the interval between treatment and recurrence was <3 months, as well as being one of the few cases that exhibited lymphatic involvement. The present report underscores the importance of further understanding the variable presentations of AdCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.